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The Coronary Artery Surgery Study (CASE., includes 7% 
paiienb wltb ndld or m~deride stable aopina pectoris or 
erjmptomatie surrivors of B myocardiil infarction who 
were randomized to either medical or sureical theraov and 
1,319 patients who were eligible for randomization hut 
were not randomized (randomizable patients). There were 
00 wbst~tlal agreg& differences &served io any oftbe 
survival comprirans atkr 10 years uf Mluw-UQ study 
behveen the randomized and randamimbk patients PI- 
signed 10 lhe medical (79% wsw 80%) or surglcnl (BLW 
ver8w 81%) groups ur in patient suhgmu~s tratified 
according to vxoaary .wtery disease xtent and let3 yen. 
trtcutar ejectton kiction. 
the randomizable group reinforce thme in thr: randomized 
group with res@?ct to the medical versus uqgnl ~onnar. 
After a decade of fotiow-up, the CAS rxndomizabk 
patients cocfirm cwclusioxs reached on the k&s of the 
CASS randomized trial. 
medical 01 surgical rranagement on a formal randomized 
basis. The data show a similar IO year survival rate for the 
medically versus surgically assigned patients (7% versus 
82%; Q = NS). When the patients were analyzed by sub- 
groups. the IO year survival rate was signdicantly greater in 
surgically assigned patients whe had an ejection fraction 
<O.SO than in patients assigned to a strategy of initial 
medical manaeement 179% versus 61%: D = 0.01). In oa- 
tients with th& vessel coronary artery disease. and ‘an 
ejection fraction <O.SO. the IO year survival rate was 75% 
versus 58% (Q = 0.08) in the surgical versus the medically 
assigned patier %s. The IO year survival rate for Qalients with 
less extensive coronary artery disease and for those with 
three vessel coronary disease and an ejection fracrion r0.50 
was similar m bath groups (I). 
The late results of the European Coronary Surgery Study 
(2) reveal a significant improvement in the survival rate in Table 1. PWty Characteristics of Randomized and 
patients with three vessel disease and normal left ventricular ftandamizable Patients -.- 
function with surgical treatment. and the Veterans Admin- Randomized Randomizable P Value 
istration randomized trial (3) reports finding similar to the 
CASS results. Diierences in the results among the three 
randomized teals have been explainad in part by differing 
baseline characteristics (4). The CASS randomized patients 
have been described (5) as a selected group at low risk who 
might have been expected to do weli from the outset. In any 
randomized study, questions arise about the extent to which 
patients are representative of the population from which 
they are drawn and how that population is representative of 
the general patient population (4-6). The CASS trial is the 
only one of the three randomized mcdicaf-surgical tria!s In 
patients with coronary artery disease that was designed in a 
manner to allow this problem to be addressed, in part, by 
caretidly collecting detailed clinical and angiographic de- 
scriptors of oarticioants and bv cneomoassina a rcaistrv of 
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ehgtare p&s &oro which the randomize;d cohort was ‘Four randcmizabk palienls excluded IKC aat); tmsassrsd in I.723 
drawn (7). phticntx AII data ID psrc$Ecdagcs except LI Med. LAD = II anterior 
From August 1975 to May 1979, 780 patients were ran- 
desctcdir: SWO~BW arten; LMCA = I& main ccwwq artery; M1 = 
domizcd to a strategy of medid management unless later 
my0cardia.l infarction: VD - vessel d&ass. 
symptoms required coronary revasculakation or coronary 
bypass grafting. There were 1,319 patients eligible for ran- 
domkation who were not randomized because the patients 
or their physicians declined participation in the randomized 
trial. The latter arc rcferrcd to as the randomizable group: 
detailed entry characteristics and 5 year survival rates in this 
group have been previously reported (81. The aim of this 
report is 1.0 1) compare the 10 year survival rate in medical 
randomixd Gth mcdieal randomizable patients and sur& 
Cal randomized with surgical randomizable patients, and 
2) examme whether inclusion in the randomized or random- 
izable cohort was a factor in determining the IO year survival 
rate. 
proximal left coronary artery disease in the randomizable 
group fTable 1). 
Randamlaed and rand~tnlaablc pafknts. Patients in the 
randomized trial were assigned to medical or surgieai Ler. 
apy on the basis of formal randomization. A randomizable 
patient wasconsidcrcdto bc in the surgicalgroupifhe or she 
had surgery within 90 days of cardiac eathctcrization or 
within the period (for that institution) in which 95% of 
patients undergohrg surgery within I year of csrdiac catha 
teriaation had surgery. whichever was grcatcr. ~Itc ~aetual 
date of surgery determined the starting point for survival 
analyses (91. Randomizable patients who did not have sur- 
gery within this time interval constitute the medical group. 
The starting time for the medical patients was assigned from 
Methods 
Siudy group. Coronary angiography was performed in 
16.626 patients at 1 I institutions participating in the random- 
ized trial from August 1.1975 to May 31,1979. Of the 16,626 
patients, 2,099 met randomization criteria; 78Owcrc random- 
ized and 1,319 constitute the randomizable group, The 
protocol was approved by the institutional review board at 
each participating institution, and all patients signed an 
informed consent form. Of the 780 randomized patients, 3% 
were assigned to the medical group and 3% to the surgical 
group. of the 1,319 randomizable patients, 745 were in the 
medical group and 570 were in the surgical group. Pascline 
characteristics of the randomized and tandootizable patients 
revealed a greater proportion of cigarette usage, hypcrten- 
sion and diabetes in the randomized Prztp and a greater 
percent of patients with single vessel raronary disease and 
tbe average time to surgery as defmcd earlier, Of the 1,319 
randomizable patients, 4 were not classified into cithcr the 
medical or the surgical group; they died before the average 
time to surgery at their institutions, did not have surgery and 
are not considered in this report. 
Angiographk and surgical descriptnrs. The number of 
diseased vessels was classified according to the number of 
htminai narrowings s70% in speck vascular territories as 
previously described (7). with the exception of the left main 
coronary artery where a 5G% luminal narrowing was conaid- 
ered important. of the 3% patients randomiacd to surgery, 
%.3% had vein grafts and 16% had internal mammary artery 
grafts, reflecting the time periud patients were enroiled into 
the CASS. Of itc $70 randomizable patients assigned to 
surgery, 98.3% had vein grafts and 10% had internal mam- 
mary artery grafts. The average number of grak inscr;ed 
was i.3 and 2,4 in the randomized and mndomizablc Pa- 
Figure 1. Medically assigned patients 
f” - 1,135). In the aggregate. tile 10 
year survival rate in randomized and 
randomizable Datienfs was similar ID = 
tients, respectively: the 30 day operative mortality rate was 
1.4% and 1.2%. respectively. 
D&a acqtittton. At entry, historical. clinical. laboratory 
rmd angiographic data were obtained for the randomized and 
randomizable patients in an identical manner. The only 
exception wes that maximal symptom-limited exercise test- 
ing and determination of hematocrit, blood creatine. glu- 
case, cholesterol and triglycerides was expected in the 
randomized patients but optional in the randomizable pa- 
tients. During the follow-up period, randomized patients 
were examined at 6 month intervals. The status of random- 
izable and other registry patients was evaluated at 12 month 
intervals. A rest electrowrdionram IECG) was obtained at 6 
month intervals for 2 years aid an~uail~ thereafter in ran- 
domized patients, whereas the ECG was obtained annually 
in randomizable ~&nts. 
Fallow-upmddetaa~Iysis. As ofSeptember& 1988. the 
mean duration of follow-up study was 10.6 years. Vital 
status is known far 778 randomized patients; 2 were lost to 
follow-ua studv a&r 4.5 and 10.5 years. reswtivel~. Ofthe 
I,:19 r&don&able patients. vital~status i known f& 1.313: 
6 were lost to followup study after an average of 6.3 years 
flange 3 to 9). 
Survival awes and time 10 surgery curves are given 
using the life table me&d. All followup data are used to 
compute the log rank statistic and two-sided p values (IO). 
To further examine whether the exwrience of the random- 
izable group is different from that if the mndomizeS 6:X‘> 
with respect to medical verus surgical comparison. Cox 
regression analyses were done with independent variables 
that hage bc:n shown to be predictors of survival in other 
studies (11.12); in addition, surgical versus medical therapy 
and claJsi6cution of the patient as randomized or nndomlz- 
able were included. After dl variables were allowed to enter 
in a stepwise mannx. the group variable (randomized or 
randomizable) was forced into the equation. This analysis 
includes all randomized and randomizable patients. Addi- 
lional analyses on patient subgroups includru analyses tnt- 
ified by number of diseased vessels. ejectian fraction and 
presence or absence of proximal left coroaary artery dis- 
ease. 
Tbo vorinbles considered in the Car analyses were: 
therapy lmedicd versus surgical). maximal stenoses of cm- 
onary artery segments, proximal left coronary srenoses, 
smoking, hypenension. diabetes mellitus, group selection 
(randomized versns randomizable). Cansdian Cardiovascu- 
lar Society angina classification (13). left main coronary 
artery disease. left ventricularcodraction score. gender, age 
and prior history of myocardial infarction. 
All p values should be interpreted cautiously because Of 
the observational nature of the data and the multiple tesls 
carried out. 
Results 
FouOw.up w&s. There were no substantial or slatisti- 
tally significant differences observed in any of the survival 
comwisons between the randomized and randomizable 
pa&s in either the medical or the surgical group (Fig, 1 to 
3, Tables 2 and 3). The IO year incidence dcoronwy bypass 
surgery was similar in the randomized and randomixble 
Datients who initiallv started in the medical grow. wit? the 
exceptio-. sf asymptomatic postmyocxdial infarctial survi- 
vow u .xre a greeter percent cf patients in the randomized 
cohcfl received surgery (40% versus 28% p = 0.02) The 
rate? of coronarv annioolastv durina the 10 vem foll@ww 
were 2.3% ?nd I:4% i. & medical r&don&d and rando&- 
izable erouos. restzectivelv. end 2.6% and 1.3% in the 
surgicaig&p; r.&rivel~. 
Figure 3. The IO year survival rate in patients Glh three vessel 
disease and proximal left coronary artery disease (stenoses 250% 
but <70% in me left main coronary artery or a7G% in the proximal 
tsft anterior descending coronary artery). Medically assigned pa- 
tients arc represented in the kft pats and sur@call~ assigned 
patients in the right pm& At baseline. patients with a” ejection 
fraction (EF) 20.50 are represenled in the uppr panel% and those 
with a” ejection fraction do.50 in the tower pan&. The “umber of 
patients at entry is indicated above the surkd curve for the 
randomized patients and below the wviwl cure for the random. 
izabte patients. 
Figure 2. Surgically assigned patients 
(n = 964,. I” the aggregate, the 10 year 
survival rates in randomized and IX”- 
domizable patients were vinually identi- 
ca, (p = 0.85,. The percentage of p”tie”U 
assigned to surgery who did not undergo 
a c”r”“ary bypass operation was small, 
with HD% of patients operated 0” 
within 6 months of randomization. 
randomizable patients and in the medical and surgical groups 
stratified by cjectio” fraction (Fig. 3). Among patients as- 
signed to the medical strategy. the percent of patients who 
underwent late wronary bypass grafting was similar in the 
randomized and randomizable groups. The results were 
similar when patients with left main coronary artery disease 
~50% to 69% were excluded. 
Cox ngrossion andyski. Cox regression anaiyses were 
applied to all of the randomized and randomizable patients. 
In no case did the initial group category (that is, being nn the 
randomized or randomizable cohort) er~ter as a signilcant 
predictor of survival. even after adjustment for prognostic 
covariates. Thus, the argument that patient selection for the 
randomized trial resulted in nonrepresentative findings is not 
supported by the data. The rafldamizable resUlts reinforce 
those of the randomized group with respect to the compar- 
ison of medical wsus surgical therapy. The IO year survival 
rate was similar for patients with one and two ve~el 
coronxy disease stntdied by ejection fraction and for pa- 
tients with three vessel coronary disease whose ejection 
frac!iora was ~0.50 (Table 4). 
The only nw subgroups for which Ihere iv a sipnifrconr 
xrrxicnl ndwroge we: I! patients with pronimai left ante- 
rior descending coiowy artery stenosis a7U% and an 
ejection fraction CO.50, and 21 those with three vessel 
coronary artery disease and an ejection fraction 4U.50. In 
both of these groups (randomized and randomizable pa- 
No. 
I YD 
EF a 0.50 
tients), coronary bypass surgery had a statisocally Ggnifi- 
cant beneficial effect on survival (p C 0.05). The reductmn in 
the mortality rate as a result of surgery is 66% for the former 
group and 44% for the group with three vessel coronary 
disease. Further stratification of the proximal left anterior 
descending artery variable was not performed becawe of 
insufficient power to test statistical differences. When Cox 
analysis of the combined randomized and randomizable 
surgical group was applied including mtemal mammary 
artery conduit ZE a covariate. the we of the arterial conduit 
was associated with a reductioo in the relative mortality risk 
of0.554 (confitence interval 0.319 to 0.9641. 
After a dec rie of follow-up study, there are no soban- 
tial or statistlsally significant differences in any of rhe 
survival comparisons between the CASS medical random- 
ized and randomizable patients or be!ween the surgical 
randomized and randomizable patients. The data confirm 
earlier observations (I .3.14) that survival after coronary 
bypss grafting is improved compared with an initial medical 
strategy in patients who have three vessel coronary disease 
andanejectionfraction <O.SO. although the difference is less 
marked at 10 years (p = 0.08). Ten year wrvival rates are 
similar in medically and surgically assigned patients with lest 
extensive coronary artery disease or those with three vessel 
coronary disease and an ejection fraction 80.50 I I). 
Baseline cbaracteristies. Detailed baseline clinical and 
artgiogmphic descriptors permit an examination of the oa- 
ticnt pool from which the randomized patients were ;e- 
lected. There are differences between baseline characteris- 
tics of the randomized and randomizable patients when 
examined in the aggregate (Table IL illustrating that a 
greater proportion of the randomized patients were cigarette 
smokers and had hypertension and disbetes. In addition. the 
randomized cohort was less likely to have single vessel 
coronary disease. proximal left coronary artery disease or a 
normal ejection fraction. Thus. although the differences we 
small. the randomized patient on the average had a wane 
atherosclerotic risk profile, poorer left ventricular function. 
a similar extent of multivessel coronary disease and slightly 
less frequent proximal left coronary artery disease. We 
cannot rule out the possibility that there are differences in 
unmzaured variables between the two groups that might be 
important, even though we selected baseline variables 
effect of group assignment after adjustment for ~mpa~ant 
prognosw covdriates on the over& conclusions of the 
C4SS by rrealmg the randomized and radomizab!e patients 
as one larger group of subjects under observation. We 
included the croup assignment as a I ovariate. Group assign- 
ment rsfers to whether the patient is in the randomized or 
nndomw.blc gro’lp. This important indicator variable ad- 
jut, for other potentially prognostic fwors that might have 
gone nnmeawrcd but were used by :he physician !o dcter- 
mint whether or not an indiwdual wald be randomized. The 
adjurtment for covariates is alw important because it oartlv 
anwerc the question ar to whethe; the results would havk 
been ddTercnt in the randomizable group because they had 
more or lesr severe disease or a ditfcrent mix of digease 
categories (that is. comparing wrgery and medicine afier 
adjustment for possible differences in !he severity of dipease 
m the wgically or medically treated patients). When this 
was done. overall (that is. for the entire group of patients). 
there wrc no differences beiween medical and surgical 
sur\ivaI rates or significant differences between medical 
~urwval rates NI randomized versus randomizable paticots or 
between curgical survival raw for randomized versus ran- 
domhable patients. Analysis by subgroup confirms the re- 
ported results ofthe CASS randomized trial in that the only 
subgroups that show statistical significance are those with a 
low ejectlon fraction. patients with three vessel coronary 
artery disease and those with disease of the left anterior 
descending coronary artery. 
Clearly. the overwhelming impression from the resuhs of 
the CASS randomized and randomizable groups of patients 
is that among these mildly symptomatic patients the survival 
rates of the randomized and randomizable patients who 
received either initial medical therapy or corbnary bypass 
craftine are hasicallv ideniical. We believe that the CASS 
~esults~can be e&p&ted to the larger group of patients 
with coronary anery disease who meer CASS entry and 
exclusion criteria. The CASS randomized and randomizable 
data should nor be extrapolated to other groups of patients 
with coronary artery disease who do not meet these criteria. 
Slalislical power. The CASS had relatively few patients 
with a poor ejection frwtion in the randomized group. 
Clearly. in a consecutive series of patients undergoing car- 
diac catheterization, patients who have marked impairment 
of left ventricular function and sing!e vessel coronary dis- 
ease are uncommon; in the CASS. only I9 such patients 
knawn to be important from previous data (I I, 12). In CASS were randomized. However. in the randomizable group. we 
patients. analysis of therapeutic effect has always heen find exactly the swne results: there is no improvement in the 
reported an the basis of clinical. anatomic and functional IO year survival rate as a result of coronary bypass grafting. 
subgroups. In fact, the surgical-medical curves are supetimpsable. The 
Impaet ofgwup assignment. A major question is whether same holds true for patients with two vessel coronary artery 
any differences between the randomized and randomizable disease. The statistical power to examine therapeutic differ- 
groups have an impact on survival in terms of the overall ewes would be greater if a larger patient sample were 
conclusions of the CASS. WC addressed the issue of the obtained. The evidence from our IO year data. however, is 
that ihere is little ddkence betweea medical and surgical 
thernpy in these subgroups. 
Conclusions. There are no substantial or statie,ically sig- 
nificant differences in any of ,he survival comparisons be- 
,ween ,he CASS randomized and randomizable patients 
assigned to medical or surgical rherapy. Even when CASS 
randomized and randomizable palienls are considered in the 
aggregate (that is, as if they were one group of patients in an 
observational study). one would come 10 exactly the same 
conclusion as was reached on the basis of the CASS ran- 
domized vial. In essence, the CASS conclusions remain 
correct even after a decade of follow-up study and careful 
examination of the randomized and randomizable groups. 
